Hollister-Stier Laboratories (TwinJect Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 2

Hollister-Stier Laboratories (TwinJect Rights) General Information

Description

An emergency supportive therapy used for the treatment of severe allergic reactions and anaphylaxis.The product is designed as an emergency supportive therapy for immediate treatment of Anaphylaxis which is a sudden, severe, and potentially life-threatening allergic reaction triggered by exposure to one or more allergens, including foods, insect stings, drugs, and latex products and is indicated in the emergency treatment of this severe allergic reaction.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Spokane, WA
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Therapeutic Devices
Acquirer
Vertical(s)
Corporate Office
  • Spokane, WA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hollister-Stier Laboratories (TwinJect Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hollister-Stier Laboratories (TwinJect Rights)‘s full profile, request access.

Request a free trial

Hollister-Stier Laboratories (TwinJect Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hollister-Stier Laboratories (TwinJect Rights)‘s full profile, request access.

Request a free trial

Hollister-Stier Laboratories (TwinJect Rights) FAQs

  • Where is Hollister-Stier Laboratories (TwinJect Rights) headquartered?

    Hollister-Stier Laboratories (TwinJect Rights) is headquartered in Spokane, WA.

  • What industry is Hollister-Stier Laboratories (TwinJect Rights) in?

    Hollister-Stier Laboratories (TwinJect Rights)’s primary industry is Buildings and Property.

  • Is Hollister-Stier Laboratories (TwinJect Rights) a private or public company?

    Hollister-Stier Laboratories (TwinJect Rights) is a Private company.

  • What is the current valuation of Hollister-Stier Laboratories (TwinJect Rights)?

    The current valuation of Hollister-Stier Laboratories (TwinJect Rights) is .

  • What is Hollister-Stier Laboratories (TwinJect Rights)’s current revenue?

    The current revenue for Hollister-Stier Laboratories (TwinJect Rights) is .

  • Who are Hollister-Stier Laboratories (TwinJect Rights)’s investors?

    HollisterStier Allergy, Verus Pharmaceuticals, and Windward Capital Advisors have invested in Hollister-Stier Laboratories (TwinJect Rights).

  • When was Hollister-Stier Laboratories (TwinJect Rights) acquired?

    Hollister-Stier Laboratories (TwinJect Rights) was acquired on 13-Mar-2008.

  • Who acquired Hollister-Stier Laboratories (TwinJect Rights)?

    Hollister-Stier Laboratories (TwinJect Rights) was acquired by Sciele Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process